Webinar
Integrated Evidence Generation: From planning to practice
September 11, 2024
In areas like rare diseases, planning how to obtain evidence is crucial. This involves bringing non-traditional methodologies into the evidence generation process to demonstrate value to payers, patients, and healthcare providers.
Understanding this approach through tested models helps accelerate the registration pathway, bringing solutions for unmet needs to clinical practice.
This webinar will discuss:
The Importance of Early Access Planning
- Risks and impacts of neglecting access considerations
- Effects on patient reach, pricing, and time-to-market
Understanding Payer Perspectives
- Evidence requirements for payers
- Specific considerations for rare diseases
- Payer viewpoints on cell and gene therapies
Incorporating Access into Drug Development Timelines
- Key milestones and integration strategies
- Case studies of successful implementation
Enabling evidence at scale
- Innovative frameworks and infrastructure for stakeholder needs
- Integrated evidence platforming across product lifecycle
- Real-world case studies and best practices for scalable evidence generation
Shruti MP
Director, RWD Solutions
Shruti has over 16 years’ of clinical research experience in real world data (RWD) solutioning, medical writing, product strategy and medical communications, at Parexel and at GlaxoSmithKline. She has broad experience in the development and implementation of scientific data-enabled solutions in clinical trials and RWE studies, across the product development lifecycle. In her current role, Shruti leads operational delivery of studies with novel approaches using RWD and related technologies, while advising on recommended strategies for expanded access to scientific data. She holds a MSc in Biochemistry from Bangalore University, India.